A wide variety of presentations include pharmacokinetics (PK) and safety analyses from the study of VALTOCO® (diazepam nasal spray) for the treatment of seizure clusters in patients with epilepsy ...
SAN DIEGO, Dec. 6, 2024 /PRNewswire/ -- Neurelis, Inc., today announced details of its presentations at the American Epilepsy Society (AES) Annual Meeting to be held December 6-10 in Los Angeles. The ...
Valtoco (diazepam) is a prescription drug that’s used to treat certain types of seizure disorders in people with epilepsy. The drug comes as a nasal spray. It’s usually given in one or both ...
A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe and well-tolerated (meaning with no significant nasal irritation ...
"It is an honor to represent Neurelis at the Expo and share my experience with VALTOCO® (diazepam nasal spray), an immediate-use seizure medication which has been key to having my son, Paul ...
Share on Pinterest Could a nasal spray help delay Alzheimer’s onset in the future? Image credit: Grace Cary/Getty Images. The number of people with dementia is forecast to almost triple by 2050.